Hyundai Motor India SUV launches and localisation underpin FY27 volume and margin recovery

Investment View and Valuation

In its July 31, 2026 result update, ICICI Direct Research maintained its BUY rating on Hyundai Motor India following a mixed Q1 FY27. The broker believes that a stronger product cycle, rising capacity utilisation, export recovery and improving localisation can support volume and earnings growth.

ICICI Direct values Hyundai Motor India at Rs 2,520 per share, based on 28 times FY28E EPS of Rs 90, versus the CMP of Rs 2,170.

Q1 FY27 Financial Performance

Hyundai Motor India reported Q1 FY27 sales volume of 1,78,082 units, down 1.3 per cent year on year and 14.5 per cent quarter on quarter. Total operating income was Rs 16,335 crore, down 0.5 per cent year on year and 13.6 per cent sequentially. Average selling price increased 0.8 per cent year on year and 2.1 per cent quarter on quarter to Rs 9.04 lakh per unit.

The quarter was characterised by ICICI Direct as mixed, without an explicit assessment of a beat or miss versus its estimates.

Domestic Business and Product Mix

Management attributed the pressure in Q1 partly to a supplier disruption and lower exports. Domestic volume nevertheless rose 5.4 per cent year on year, with April-May domestic sales increasing 13 per cent before the supplier issue. Rural contribution reached an all-time high of 26 per cent, supported by dealership expansion, service penetration and road infrastructure.

SUVs accounted for 70 per cent of domestic volumes, while CNG penetration reached a record 18.2 per cent. Hyundai Motor India held a 12.6 per cent domestic passenger-vehicle market share in FY26 and offers 14 models, including Grand i10, Aura, Verna, Exter, Venue and Creta.

Product Cycle and Domestic Growth Outlook

The broker sees a favourable domestic demand environment following GST 2.0-related affordability improvement and continued consumer preference for feature-rich, safety-oriented SUVs.

Hyundai Motor India is entering a high product-cycle phase. A mid-size ICE SUV is planned for the festive period in H2 FY27, while the company's first mass-market dedicated EV is also planned in H2 FY27.

Management said the ICE SUV will be positioned separately from Creta, using a technology-first, software-defined vehicle approach. The EV is intended to feature AI-enabled capabilities, higher localisation and eligibility under the Government's PLI scheme.

Export Recovery and FY27 Guidance

Management expects exports to recover sharply from July as logistics improve and order backlogs are served. Key export drivers include:

• The new Venue in 35 markets.
• The left-hand-drive Exter in 13 countries.
• Verna PE expansion to more than 25 markets.
• Demand from Central and South America.

Management reiterated FY27 guidance for 8-10 per cent domestic volume growth and 8-10 per cent export growth. It stated that June production losses from the supplier fire were largely recovered in July, with the balance expected to be recovered during August-September.

Margins and Earnings Estimates

Q1 margin pressure reflected lower export volumes, the supplier disruption, commodity inflation and Pune plant stabilisation costs. Management quantified commodity inflation at about 200 basis points year on year and 100 basis points sequentially, largely due to precious metals and copper. It nevertheless reaffirmed FY27 EBITDA-margin guidance of 11-14 per cent.

ICICI Direct's revised FY28 EBITDA and PAT estimates are 4.6 per cent and 7.5 per cent above its prior estimates, respectively.

Capacity Expansion and Localisation

Capacity expansion is another catalyst. Hyundai Motor India has advanced Pune's third shift to October 2026 from the earlier FY28 timeline, taking annual three-shift capacity to about 1,70,000 units.

Chennai Plant-1 utilisation is expected to improve from around 72 per cent to around 90 per cent during CY2027 as new models ramp up. Localisation is around 83 per cent, with a target of 90 per cent by 2030, supporting cost competitiveness and supply-chain resilience.

Key Risks

• Lower-than-expected FY26-FY28 sales growth from new nameplates.
• Weaker-than-expected margin recovery amid volatile raw-material prices.